Chris Butler

Stocks To Watch: FirstEnergy Corp. (FE), Sprouts Farmers Market, Inc. (SFM), Coeur Mining, Inc. (CDE)

FirstEnergy Corp. (FE) traded within a range of $30.66 to $31.23 after opening the day at $31.08. The company has seen its stock decrease in value by -0.68% so far this year. The stock was down close to -1.25% on light volume in last trading session and closed at $30.76 per share. After the recent fall, the stock is currently holding -14.11% below its 52 week high of $36.6 and 4.92% above its 12-month low of $29.33. The shares are down by over -3.52% in the last three months, and the RSI indicator value of 45.61 is neither bullish nor bearish, tempting investors to stay on the sidelines.

FirstEnergy Corp., through its subsidiaries, generates, transmits, and distributes electricity in the United States. The company operates through Regulated Distribution, Regulated Transmission, and Competitive Energy Services segments. It owns and operates coal-fired, nuclear, hydroelectric, oil and natural gas, wind, and solar power generating facilities. The company also provides energy-related products and services to retail and wholesale customers. It operates 24,211 pole miles of overhead and underground transmission lines; and electric distribution systems, including 268,682 miles of overhead pole line and underground conduit carrying primary, secondary, and street lighting circuits; as well as owns substations with a total installed transformer capacity of approximately 154,612,802 kilovolt-amperes. The company serves approximately six million customers within 65,000 square miles in Ohio, Pennsylvania, West Virginia, Maryland, New Jersey, and New York. FirstEnergy Corp. was founded in 1996 and is based in Akron, Ohio.

Sprouts Farmers Market, Inc. (SFM) failed to extend gains with the stock declining -0.1% or $-0.02 to close the day at $20.2 on active trading volume of 3.47M shares, compared to its three month average trading volume of 2.58M. The Phoenix Arizona 85054 based company has been underperforming the grocery stores group over the past 52 weeks, with the stock losing -7.55%, compared to the industry which has advanced 1.83% over the same period. With RSI of 53.01, the stock should still continue to rise and get closer to its one year target estimate of $24.13, making it a hold for now.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Coeur Mining, Inc. (CDE) dropped $-0.13 to close the day at a new closing price of $11.47, a -1.12% decrease in value from its previous closing price that moved the stock 608.02% above its 52 week low of $1.68. A total of 3.46M shares exchanged hands during the day compared with its three month average trading volume of 4.47M. The stock, which fluctuated between $11.31 and $11.81 during the day, currently situated -30.1% below its 52 week high. The stock is up by 27.44% in the past one month and up by 5.81% over the past three months. With a one year target estimate of $13.06 and RSI of 64.22, the stock still has upside potential, making it a hold for now.

Coeur Mining, Inc. owns, operates, explores for, and develops silver and gold properties. The company holds interests in the Palmarejo silver-gold mine located in Mexico; Rochester silver and gold mine in northwestern Nevada; Kensington gold mine located to the north of Juneau, Alaska; and Wharf gold mine in South Dakota. It also owns the San Bartolomé silver mine in Bolivia; Endeavor zinc, lead, and silver mine located in Australia; La Preciosa silver-gold exploration project in the State of Durango, Mexico; and Joaquin silver-gold exploration project located in the Santa Cruz province of southern Argentina. In addition, the company holds royalty interests in the Cerro Bayo mine in Chile; El Gallo complex in Mexico; Zaruma mine in Ecuador; and Correnso gold mine in New Zealand, as well as other precious metal properties. Coeur Mining, Inc. markets its silver and gold concentrates to third-party refiners and smelters in the United States, China, and Japan. The company was formerly known as Coeur d’Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was founded in 1928 and is based in Chicago, Illinois.

 

3 Stocks in Focus: Zayo Group Holdings, Inc. (ZAYO), aTyr Pharma, Inc. (LIFE), Skyworks Solutions, Inc. (SWKS)

Zayo Group Holdings, Inc. (ZAYO) fell -0.16% during last trading as the stock lost $-0.05 to finish the day at $32 with about 3.11M shares changing hands, compared to its three month average trading volume of 3.22M. The $7.62B market cap company, which fluctuated between $31.68 and $32.05 during the day, currently situated 63.35% above its 52 week low of $19.59 and -10.24% away from its one year high of $35.65. The RSI of 45.45 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Zayo Group Holdings, Inc., through its subsidiaries, provides bandwidth infrastructure solutions for the communications industry in the United States, Canada, and Europe. The company operates in five segments: Dark Fiber Solutions, Network Connectivity, Colocation and Cloud Infrastructure, Zayo Canada, and Other. The Dark Fiber Solutions segment provides dark fiber, and fiber-to-the-tower and small cell mobile infrastructure services for carriers and other communication service providers, Internet service providers, wireless service providers, media and content companies, large enterprises, and other companies. The Network Connectivity segment offers bandwidth infrastructure solutions comprising wavelength, Ethernet, Internet protocol, and SONET services through its metro, regional, and long-haul fiber networks for carriers, financial services companies, healthcare, government institutions, education institutions, and other enterprises. The Colocation and Cloud Infrastructure segment provides data center infrastructure solutions, including colocation, interconnection, cloud, hosting, and managed services to a range of enterprise, carrier, content, and cloud customers. The Zayo Canada segment offers dark fiber, network connectivity, cloud and colocation infrastructure, voice, unified communications, and managed security services for small and medium business customers. The Other segment provides network and technical resources to customers in designing, acquiring, and maintaining their networks. The company was founded in 2007 and is headquartered in Boulder, Colorado.

aTyr Pharma, Inc. (LIFE) gained $0.8 to close the day at a new closing price of $3.25, a 32.65% increase in value from its previous closing price that moved the stock 54.76% above its 52 week low of $2.1. A total of 3.1M shares exchanged hands during the day compared with its three month average trading volume of 169.95K. The stock, which fluctuated between $2.7 and $3.45 during the day, currently situated -52.28% below its 52 week high. The stock is up by 38.3% in the past one month and up by 20.37% over the past three months. With a one year target estimate of $3.67 and RSI of 64.99, the stock still has upside potential, making it a hold for now.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-girdle muscular dystrophy 2B or FSHD. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.

Skyworks Solutions, Inc. (SWKS) had a active trading with around 3.1M shares changing hands compared to its three month average trading volume of 2.15M. The stock traded between $77.16 and $79.27 before closing at the price of $79.27 with 3.1% change on the day. The Woburn Massachusetts 01801 based company is currently trading 47.21% above its 52 week low of $54.5 and -3.29% below its 52 week high of $82.28. Both the RSI indicator and target price of 58.16 and $86.3 respectively, lead us to believe that it should be put on hold over the coming weeks.

Skyworks Solutions, Inc., together with its subsidiaries, designs, develops, manufactures, and markets proprietary semiconductor products, including intellectual property worldwide. Its product portfolio includes amplifiers, attenuators, circulators/isolators, DC/DC converters, demodulators, detectors, diodes, directional couplers, diversity receive modules, filters, front-end modules, hybrids, LED drivers, low noise amplifiers, mixers, modulators, optocouplers/optoisolators, phase shifters, phase locked loops, power dividers/combiners, receivers, switches, synthesizers, technical ceramics, voltage controlled oscillators/synthesizers, and voltage regulators. The company provides its products for automotive, broadband, cellular infrastructure, connected home, industrial, medical, military, smartphone, tablet, and wearable applications. Skyworks Solutions, Inc. sells its products through direct sales force, electronic component distributors, and independent sales representatives. The company was founded in 1962 and is headquartered in Woburn, Massachusetts.

 

3 Trending Stocks: CBL & Associates Properties, Inc. (CBL), Allergan plc (AGN), Peregrine Pharmaceuticals, Inc. (PPHM)

CBL & Associates Properties, Inc. (CBL) continued its downward trend with the stock declining -1.56% or $-0.17 to close the day at $10.73 on active trading volume of 2.68M shares, compared to its three month average trading volume of 2.06M. The Chattanooga Tennessee 37421 based company has been outperforming the reit – retail group over the past 52 weeks, with the stock gaining 10.35%, compared to the industry which has advanced 5.87% over the same period. With RSI of 37.57, the stock should still continue to rise and get closer to its one year target estimate of $12.85, making it a hold for now.

CBL & Associates Properties, Inc. is a public real estate investment trust. It engages in acquisition, development, and management of properties. The fund invests in the real estate markets of United States. Its portfolio consists of enclosed malls and open-air centers. CBL & Associates Properties is based in Oak Brook, Illinois. CBL & Associates Properties was founded in 1978 and is based in Chattanooga, Tennessee with additional offices in Waltham, Massachusetts; Chesterfield, Missouri; and Irving, Texas.

Allergan plc (AGN) climbed 0.83% during last trading as the stock added $1.78 to finish the day at $216.56 with about 2.66M shares changing hands, compared to its three month average trading volume of 5.16M. The $81.26B market cap company, which fluctuated between $214.7 and $219.13 during the day, currently situated 17.38% above its 52 week low of $184.5 and -28.29% away from its one year high of $301.98. The RSI of 65.13 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women’s health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer’s disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians’ offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.

Peregrine Pharmaceuticals, Inc. (PPHM) saw its value increase by 4.07% as the stock gained $0.01 to finish the day at a closing price of $0.3. The stock was higher in trading and has fluctuated between $0.282-$1.12 per share for the past year. The shares are down by -11.24% in the past three months and down by -20.58% over the past six months. It is currently trading -2.33% below its 20 day moving average and -3.39% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $1.25 a share over the next twelve months. The current relative strength index (RSI) reading is 46.89. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It’s lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy and related support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; Merck KGaA; and National Comprehensive Cancer Network, as well as collaboration agreement with AstraZeneca PLC and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.

 

Stocks on the Move: State Street Corporation (STT), DexCom, Inc. (DXCM), Uranium Resources, Inc. (URRE)

State Street Corporation (STT) continued its downward trend with the stock declining -0.06% or $-0.05 to close the day at $80.15 on active trading volume of 2.37M shares, compared to its three month average trading volume of 2.16M. The Boston Massachusetts 02111 based company has been outperforming the asset management group over the past 52 weeks, with the stock gaining 47.63%, compared to the industry which has advanced 28.89% over the same period. With RSI of 50.31, the stock should still continue to rise and get closer to its one year target estimate of $85.62, making it a hold for now.

State Street Corporation, through its subsidiaries, provides a range of financial products and services to institutional investors worldwide. The company offers investment servicing products and services, including custody; product- and participant-level accounting; daily pricing and administration; master trust and master custody; record-keeping; cash management; foreign exchange, brokerage, and other trading services; securities finance; deposit and short-term investment facilities; loans and lease financing; investment manager and alternative investment manager operations outsourcing; and performance, risk, and compliance analytics. It also provides investment management services, such as investment management, investment research, and investment advisory services to corporations, public funds, and other sophisticated investors, as well as offers active and passive asset management strategies across equity, fixed-income, and cash asset classes. The company offers its products and services to mutual funds, collective investment funds and other investment pools, corporate and public retirement plans, insurance companies, foundations, endowments, and investment managers. State Street Corporation was founded in 1792 and is headquartered in Boston, Massachusetts.

DexCom, Inc. (DXCM) fell -1.56% during last trading as the stock lost $-1.33 to finish the day at $84.16 with about 2.36M shares changing hands, compared to its three month average trading volume of 1.53M. The $5.65B market cap company, currently situated 75.63% above its 52 week low of $47.92 and -12.68% away from its one year high of $96.38. The RSI of 75.83 indicates the stock is overbought at the current levels, sell for now.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring; and DexCom G5 Mobile, a continuous glucose monitoring system. The company’s in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers; and sensor augmented insulin pumps. The company markets its products directly to endocrinologists, physicians, and diabetes educators. It has collaboration agreements with Animas Corporation and Tandem Diabetes Care, Inc. The company was founded in 1999 and is headquartered in San Diego, California.

Uranium Resources, Inc. (URRE) saw its value decrease by -9.87% as the stock dropped $-0.23 to finish the day at a closing price of $2.1. The stock was higher in trading and has fluctuated between $0.97-$5.1 per share for the past year. The shares are up by 60.31% in the past three months and up by 34.62% over the past six months. It is currently trading 21.46% above its 20 day moving average and 41.34% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $3.25 a share over the next twelve months. The current relative strength index (RSI) reading is 55.35. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Uranium Resources, Inc. explores for, develops, and produces uranium. The company has in-situ recovery (ISR) projects and two licensed processing facilities. It owns and operates the Temrezli ISR project in Central Turkey; and controls exploration properties under nine exploration and operating licenses covering approximately 32,000 acres with various exploration targets, including the Sefaatli project. The company also holds interest in approximately 190,000 acres of mineral holdings in the prolific Grants Mineral Belt of the State of New Mexico; and 14,000 acres in the South Texas uranium province. In addition, it holds an agreement to acquire certain placer mining claims in the Sal Rica lithium brine project that covers an area of approximately 9,800 acres located in the Pilot Valley region of northwestern Utah. Uranium Resources, Inc. was founded in 1977 and is based in Centennial, Colorado.

 

Equities Trend Analysis: Fortinet, Inc. (FTNT), Alexion Pharmaceuticals, Inc. (ALXN), Danaher Corporation (DHR)

Fortinet, Inc. (FTNT) grew with the stock adding 0.47% or $0.15 to close at $31.85 on light trading volume of 2.12M compared its three months average trading volume of 2.5M. The Sunnyvale California 94086 based company operating under the Application Software industry has been trending up for the last 52 weeks, with the shares price now 20.37% up for the period and up by 5.74% so far this year. With price target of $35.48 and a 37.52% rebound from 52-week low, Fortinet, Inc. has plenty of upside potential, making it a hold with a view buy.

Fortinet, Inc. provides cyber security solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and virtual appliances products that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, Web filtering, anti-spam, and wide area network acceleration; FortiManager product family to provide a central management solution for FortiGate products comprising software updates, configuration, policy settings, and security updates; and the FortiAnalyzer product family, which provides a single point of network log data collection. It also offers FortiAP secure wireless access points; FortiWeb, a Web application firewall; FortiMail email security; FortiDB database security appliances; FortiClient, an endpoint security software; and FortiSwitch secure switch connectivity products. In addition, the company provides FortiSandbox advanced threat protection solutions; and FortiDDos and FortiDB database security appliances. Further, it offers security subscription, technical support, training, and professional services. The company was founded in 2000 and is headquartered in Sunnyvale, California.

Alexion Pharmaceuticals, Inc. (ALXN) had a light trading with around 2.12M shares changing hands compared to its three month average trading volume of 3.21M. The stock traded at the price of $135.87 with 0.42% change on the day. The New Haven Connecticut 06510 based company is currently trading 24.51% above its 52 week low of $109.12 and -17.01% below its 52 week high of $162. Both the RSI indicator and target price of  and $169.45 respectively, lead us to believe that it could rise over the coming weeks.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia (HPP); and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH registry; Phase III clinical trials for the treatment of myasthenia gravis, neuromyelitis optica spectrum disorder, and delayed kidney transplant graft function; and Phase II clinical trials for antibody mediated rejection in presensitized renal transplant patients. It develops cPMP (ALXN 1101) that is in Phase II/III trial for treating metabolic disorders; and ALXN 1007, a novel humanized antibody in Phase II clinical trial for the treatment of anti-phospholipid syndrome and graft versus host disease. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other health care providers, as well as governments and government agencies in the United States, Europe, the Asia Pacific, and internationally. Alexion Pharmaceuticals, Inc. has agreements with X-Chem Pharmaceuticals (X-Chem) to identify novel drug candidates from X-Chem’s proprietary drug discovery engine; Moderna Therapeutics, Inc. (Moderna) that provides the option to purchase drug products for clinical development commercialization of Moderna’s messenger RNA therapeutics to treat rare diseases; and Ensemble Therapeutics Corporation for the identification, development, and commercialization of therapeutic candidates based on specific drug targets. The company was founded in 1992 and is headquartered in New Haven, Connecticut.

Danaher Corporation (DHR) saw its value increase by 0.35% as the stock gained $0.28 to finish the day at a closing price of $81.19. The stock was lighter in trading and has fluctuated between $61.6-$82.64 per share for the past year. The shares, which traded within a range of $81 to $81.6 during the day, are up by 7.2% in the past three months and up by 0.7% over the past six months. It is currently trading 2.15% above its 20 day moving average and 2.89% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $89.72 a share over the next twelve months. The current relative strength index (RSI) reading is 62.11.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company’s Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company’s Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company’s Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

 

3 Stocks in Focus: Equity Residential (EQR), PG&E Corporation (PCG), Analog Devices, Inc. (ADI)

Equity Residential (EQR) climbed 0.19% during last trading as the stock added $0.12 to finish the day at $63.6 with about 2.11M shares changing hands, compared to its three month average trading volume of 2.2M. The $23.52B market cap company, which fluctuated between $63.14 and $64.13 during the day, currently situated 9.27% above its 52 week low of $58.28 and -10.35% away from its one year high of $79.9. The RSI of 52.38 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Equity Residential, a real estate investment trust (REIT), engages in the acquisition, development, and management of multifamily properties in the United States. As of December 31, 2007, it owned and invested in 579 properties in 24 states and the District of Columbia consisting of 152,821 units. The company qualifies as a REIT for federal income tax purposes. As a REIT, it would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. Equity Residential was founded in 1966 and is headquartered in Chicago, Illinois.

PG&E Corporation (PCG) dropped $-0.32 to close the day at a new closing price of $61.46, a -0.52% decrease in value from its previous closing price that moved the stock 25.22% above its 52 week low of $50.8. A total of 2.11M shares exchanged hands during the day compared with its three month average trading volume of 2.3M. The stock, which fluctuated between $61.36 and $61.76 during the day, currently situated -4.57% below its 52 week high. The stock is up by 3.24% in the past one month and up by 2.58% over the past three months. With a one year target estimate of $65.72 and RSI of 59.26, the stock still has upside potential, making it a hold for now.

PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California. The company’s electricity distribution network consists of approximately 142,000 circuit miles of distribution lines, 58 transmission switching substations, and 603 distribution substations; and electricity transmission network comprises approximately 18,400 circuit miles of interconnected transmission lines and 91 electric transmission substations. Its natural gas system consists of approximately 42,800 miles of distribution pipelines, approximately 6,700 miles of backbone and local transmission pipelines, and various storage facilities. The company operates various electricity generation facilities, such as nuclear, hydroelectric, fossil fuel-fired, and photovoltaic. PG&E Corporation was founded in 1905 and is headquartered in San Francisco, California.

Analog Devices, Inc. (ADI) had a light trading with around 2.11M shares changing hands compared to its three month average trading volume of 2.58M. The stock traded at the price of $73.01 with 1.01% change on the day. The Norwood Massachusetts 02062 based company is currently trading 55.82% above its 52 week low of $47.24 and -2.42% below its 52 week high of $74.87. Both the RSI indicator and target price of 56.62 and $78.7 respectively, lead us to believe that it should be put on hold over the coming weeks.

Analog Devices, Inc. designs, manufactures, and markets a portfolio of solutions that leverage analog, mixed-signal, and digital signal processing technology, including integrated circuits (ICs), algorithms, software, and subsystems. It offers data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; high-performance amplifiers to condition analog signals; and radio frequency ICs to support cellular infrastructure. The company also provides MEMS technology solutions, including accelerometers used to sense acceleration, gyroscopes to sense rotation, and inertial measurement units to sense multiple degrees of freedom. In addition, it offers isolators for various applications, such as universal serial bus isolation in patient monitors; and smart metering and satellite applications. Further, the company provides power management and reference products; and digital signal processing products for high-speed numeric calculations. Its products are used in electronic equipment, including industrial process control systems, medical imaging equipment, factory automation systems, patient monitoring devices, instrumentation and measurement systems, wireless infrastructure equipment, energy management systems, networking equipment, aerospace and defense electronics, optical systems, automobiles, and portable electronic devices. The company serves clients in industrial, automotive, consumer, and communications markets through a direct sales force, third-party distributors, and independent sales representatives in the United States, rest of North/South America, Europe, Japan, China, and rest of Asia, as well as through its Website. It has a collaboration with TriLumina Corp. to provide illuminator modules for automotive flash LiDAR systems. Analog Devices, Inc. was founded in 1965 and is headquartered in Norwood, Massachusetts.

 

3 Stocks to Watch For: AmerisourceBergen Corporation (ABC), The Boeing Company (BA), Citrix Systems, Inc. (CTXS)

AmerisourceBergen Corporation (ABC) saw its value decrease by -0.56% as the stock dropped $-0.48 to finish the day at a closing price of $85.51. The stock was lighter in trading and has fluctuated between $68.38-$92.48 per share for the past year. The shares, which traded within a range of $85.19 to $86.18 during the day, are up by 7.73% in the past three months and up by 0.37% over the past six months. It is currently trading 5.11% above its 20 day moving average and 8.31% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $86.3 a share over the next twelve months. The current relative strength index (RSI) reading is 61.81.The technical indicator lead us to believe there will be no major movement any time soon, hold.

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company’s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

The Boeing Company (BA) shares were up in last trading by 0.41% to $158.32. It experienced lighter than average volume on day. The stock decreased in value by almost -0.47% over the past week and grew 2.96% in the past month. It is currently trading 3.69% above its 50 day moving average and 16.61% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.09% decrease in value from its one year high of $160.07. The RSI indicator value of 60.26, lead us to believe that it is a hold for now.

The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for various passenger and cargo requirements, as well as provides related support services to the commercial airline industry. This segment also offers aviation services support, aircraft modifications, spare parts, training, maintenance documents, and technical advice to commercial and government customers. The Boeing Military Aircraft segment is involved in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems for the global strike, vertical lift, and autonomous systems, as well as mobility, surveillance, and engagement. The Network & Space Systems segment engages in the research, development, production, and modification of electronics and information solutions; strategic missile and defense systems; space and intelligence systems; and space exploration products. The Global Services and Support segment offers integrated logistics, including supply chain management and engineering support; maintenance, modification, and upgrades for aircraft; and training systems and government services, such as pilot and maintenance training. The Boeing Capital segment facilitates, arranges, structures, and provides financing solutions, such as equipment under operating leases, finance leases, notes and other receivables, assets held for sale or re-lease, and investments. The Boeing Company was founded in 1916 and is headquartered in Chicago, Illinois.

Citrix Systems, Inc. (CTXS) opening the day at $91.13. The company has seen its stock increase in value by 4.76% so far this year. The stock was up close to 2.93% on active volume in last trading session and closed at $93.56 per share. After the recent gain, the stock is currently holding 1.26% above its 52 week high of $93.63 and 53.6% above its 12-month low of $60.91. The shares are up by over 12.49% in the last three months, and the RSI indicator value of 64.9 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Citrix Systems, Inc. develops and sells products and services that enable delivery of applications and data over public, private, or hybrid clouds or networks to various types of devices. The company’s Enterprise and Service Provider segment provides XenDesktop, a desktop virtualization system that gives customers the flexibility to deliver desktops and applications as cloud services; XenApp that allows Windows applications to be delivered as cloud services to Android and iOS mobile devices, Macs, PCs, and thin clients; XenMobile Enterprise to manage mobile devices, apps, and data; Citrix Workspace Suite, a business mobility solution; and NetScaler, an all-in-one application delivery controller. Its Mobility Apps segment provides GoToMeeting for online meetings, sales demonstrations, and collaborative gatherings; GoToWebinar, a do-it-yourself Webinar product; GoToTraining, an online training product; OpenVoice, a reservation-less audio conferencing service; and Grasshopper, a cloud-based telephony solutions for small businesses. This division also provides ShareFile, a cloud-based file sharing and storage solution for businesses; GoToMyPC, an online service that enables mobile workstyles by providing remote access to a PC or Mac from virtually Internet-connected computer, as well as from supported iOS or Android mobile devices; and GoToAssist, which offers cloud-based information technology support solutions. In addition, it offers license updates and maintenance services, including subscription, technical support, and hardware and software maintenance services; and consulting, and product training and certification services. Citrix Systems, Inc. markets and licenses its products through systems integrators, resellers, distributors, original equipment manufacturers, and service providers, as well as directly to customers worldwide. The company, formerly known as Citrus Systems, Inc., was founded in 1989 and is headquartered in Fort Lauderdale, Florida.

 

Stocks in Review: Workday, Inc. (WDAY), Kimberly-Clark Corporation (KMB), Akorn, Inc. (AKRX)

Workday, Inc. (WDAY) traded within a range of $80.38 to $82.24 after opening the day at $81.12. The company has seen its stock increase in value by 24.24% so far this year. The stock was up close to 1.38% on light volume in last trading session and closed at $82.11 per share. After the recent gain, the stock is currently holding -12.04% below its 52 week high of $93.35 and 73.52% above its 12-month low of $47.32. The shares are down by over -4.61% in the last three months, and the RSI indicator value of 69.34 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Workday, Inc. provides enterprise cloud applications for finance and human resources in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources. The company provides Workday Financial Management application that provides functions of general ledger, accounting, accounts payable, accounts receivable, cash management, asset management, employee expense management, revenue management, projects, procurement, inventory, and grants management. It also provides Workday Human Capital Management application that includes human resources management comprising workforce lifecycle management, organization management, compensation, absence, and employee benefits administration; and global talent management consisting of goal management, performance management, succession planning, and career and development planning. In addition, the company offers Workday Recruiting, an application that supports the needs of candidates, hiring managers, the interview team, and recruiters; Workday Payroll application that address the enterprise payroll needs; Workday Time Tracking application that automates workforce management processes; and Workday Professional Services Automation application. Further, it offers Workday Insight Applications that leverage advanced data science and machine learning methodologies to help customers make smarter financial and workforce decisions; and Workday Student, a student and faculty lifecycle information system. The company serves technology, financial services, business and professional services, healthcare and life sciences, manufacturing, retail and hospitality, education, and government and non-profit industries. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was founded in 2005 and is headquartered in Pleasanton, California.

Kimberly-Clark Corporation (KMB) continued its upward trend with the stock climbing 0.32% or $0.37 to close the day at $116.4 on active trading volume of 2.02M shares, compared to its three month average trading volume of 1.91M. The Irving Texas 75038 based company has been underperforming the personal products group over the past 52 weeks, with the stock losing -4.78%, compared to the industry which has advanced 6.77% over the same period. With RSI of 60.12, the stock should still continue to rise and get closer to its one year target estimate of $121.75, making it a hold for now.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care, consumer tissue, and professional products worldwide. The Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise, and other brands. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and Jackson Safety brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce. It also sells products for away-from-home use through distributors and directly to manufacturing, lodging, office building, food service, and public facilities. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Akorn, Inc. (AKRX) dropped $-0.38 to close the day at a new closing price of $20.87, a -1.79% decrease in value from its previous closing price that moved the stock 18.78% above its 52 week low of $17.57. A total of 2.01M shares exchanged hands during the day compared with its three month average trading volume of 1.68M. The stock, currently situated -41.05% below its 52 week high. The stock is up by 2.81% in the past one month and down by -21.33% over the past three months. With a one year target estimate of $27.62 and RSI of 43.2, the stock still has upside potential, making it a hold for now.

Akorn, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals in the United States and internationally. It operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment markets generic and branded ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. This segment’s generic products include Atropine Sulfate Ophthalmic Solution; Clobetasol Propionate Ointment; Dehydrated Alcohol Injection; Ephedrine Sulfate Injection; Hydralazine Hydrochloride Injection; Lidocaine Ointment; Methylene Blue Injection; Myorisan Soft Gelatin Capsules; Nembutal Sodium Solution; and Progesterone Capsules. The Consumer Health segment markets branded and private label animal health products, as well as OTC products for the treatment of dry eye under the TheraTears brand name. This segment also markets other OTC consumer health products, including Mag-Ox, a magnesium supplement, as well as the Diabetic Tussin line of cough and cold products. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.

 

Momentum Stocks: LifeLock, Inc. (LOCK), KB Home (KBH), E. I. du Pont de Nemours and Company (DD)

LifeLock, Inc. (LOCK) grew with the stock adding 0.08% or $0.02 to close at $23.94 on light trading volume of 1.99M compared its three months average trading volume of 2.56M. The Tempe Arizona 85281 based company operating under the Application Software industry has been trending up for the last 52 weeks, with the shares price now 82.05% up for the period and up by 0.08% so far this year. With price target of $21.33 and a 161.93% rebound from 52-week low, LifeLock, Inc. has plenty of upside potential, making it a hold with a view buy.

LifeLock, Inc. provides identity theft protection services for consumers; and consumer risk management services for enterprises in the United States. It operates in two segments, Consumer and Enterprise. It protects consumer subscribers through monitoring identity-related events, such as new account openings and credit-related applications; and enterprise customers by delivering on-demand identity risk, identity authentication, and credit information about consumers. The company offers LifeLock Identity Alert system, which provides its members with notifications and alerts, including actionable alerts for new account openings and applications, as well as a response system for identity threats via text message, phone call, mobile application, or e-mail; LifeLock Standard, LifeLock Advantage, LifeLock Ultimate Plus, basic LifeLock, LifeLock Command Center, and premium LifeLock Ultimate services; LifeLock Junior service, which provides identity theft protection services for minors; and LifeLock Benefit Elite that provides identity theft protection for employers and brokers. It also provides ID Score, an identity risk service, which delivers on-demand assessment of the risk of an individual at account opening and throughout the customer lifecycle; and credit risk services that provide real-time visibility into consumer stability. As of December 31, 2015, the company served approximately 4.2 million paying members; and 350 enterprise customers, including financial institutions, telecommunication and cable services providers, government agencies, technology companies, retailers, automobile and mortgage lenders, and e-commerce providers. LifeLock, Inc. was founded in 2005 and is headquartered in Tempe, Arizona.

KB Home (KBH) had a light trading with around 1.99M shares changing hands compared to its three month average trading volume of 2.49M. The stock traded between $16.39 and $16.81 before closing at the price of $16.51 with -0.84% change on the day. The Los Angeles California 90024 based company is currently trading 84% above its 52 week low of $9.34 and -5.01% below its 52 week high of $17.38. Both the RSI indicator and target price of  and $16.96 respectively, lead us to believe that it could rise over the coming weeks.

KB Home operates as a homebuilding company in the United States. It constructs and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers. The company also provides property and casualty insurance, as well as earthquake, flood, and personal property insurance to its homebuyers; title services; and mortgage banking services, including residential mortgage loan originations to its homebuyers. It has operations in California, Arizona, Nevada, Colorado, Florida, Maryland, North Carolina, and Texas. The company was formerly known as Kaufman and Broad Home Corporation and changed its name to KB Home in January 2001. KB Home was founded in 1957 and is headquartered in Los Angeles, California.

  1. I. du Pont de Nemours and Company (DD) saw its value increase by 0.66% as the stock gained $0.48 to finish the day at a closing price of $73.45. The stock was lighter in trading and has fluctuated between $50.71-$75.86 per share for the past year. The shares, which traded within a range of $72.62 to $73.6 during the day, are up by 7.56% in the past three months and up by 10.03% over the past six months. It is currently trading -1.02% below its 20 day moving average and 1.3% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $78.07 a share over the next twelve months. The current relative strength index (RSI) reading is 50.95.The technical indicator lead us to believe there will be no major movement any time soon, hold.
  2. I. du Pont de Nemours and Company operates as a science and technology based company. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, rice, seed products, herbicides, fungicides, and insecticides, as well as offers crop protection products, such as weed control, disease control, and insect control products. Its Electronics & Communications segment provides various materials and systems, including photopolymers and electronic materials for photovoltaic, consumer electronics, displays, and advanced printing. The company’s Industrial Biosciences segment develops and manufactures a portfolio of enzymes and bio-based materials. Its Nutrition & Health segment offers cultures, probiotics, texturants, emulsifiers, natural sweeteners, and soy-based food ingredients for the food industry market. The company’s Performance Materials segment offers elastomers and thermoplastic, and thermoset engineering polymers; resins and films for packaging and industrial polymer applications, sealants and adhesives, and sporting goods; and elastomers, parts, and systems and solutions for automotive and transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor, and aerospace markets. Its Safety & Protection segment provides nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The company markets its products through the company’s sales force and distributors in the United States and internationally. E. I. du Pont de Nemours and Company was founded in 1802 and is headquartered in Wilmington, Delaware.

 

Stocks In Action: Zoetis Inc. (ZTS), Carnival Corporation (CCL), Monster Beverage Corporation (MNST)

Zoetis Inc. (ZTS) traded within a range of $53.04 to $54.01 after opening the day at $53.39. The company has seen its stock decrease in value by -0.43% so far this year. The stock was up close to 0.15% on light volume in last trading session and closed at $53.3 per share. After the recent gain, the stock is currently holding -2.6% below its 52 week high of $54.72 and 40.17% above its 12-month low of $38.26. The shares are up by over 6.75% in the last three months, and the RSI indicator value of 56.89 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia, pain management, and the diagnosis of diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, as well as products and services in complementary areas consisting of biodevices, diagnostics, and genetics. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

Carnival Corporation (CCL) managed to rebound with the stock climbing 0.96% or $0.51 to close the day at $53.6 on light trading volume of 3.19M shares, compared to its three month average trading volume of 3.58M. The Miami Florida 33178 based company has been outperforming the resorts & casinos group over the past 52 weeks, with the stock gaining 12.31%, compared to the industry which has advanced 29.32% over the same period. With RSI of 56.1, the stock should still continue to rise and get closer to its one year target estimate of $57.09, making it a hold for now.

Carnival Corporation operates as a leisure travel and cruise company in North America, Europe, Australia, and Asia. It offers cruises under the Carnival Cruise Line, Princess Cruises, Holland America Line, and Seabourn brands in North America; and Costa, AIDA, P&O Cruises (UK), Cunard, and P&O Cruises (Australia) brands in Europe, Australia, and Asia. The company operates 99 cruise ships. It also owns Holland America Princess Alaska Tours, a tour company in Alaska and the Canadian Yukon, which owns and operates 11 hotels or lodges, approximately 300 motor coaches, and 20 glass-domed railcars. In addition, the company is involved in the leasing of cruise ships. It sells its cruises primarily through travel agents and tour operators. Carnival Corporation was incorporated in 1972 and is headquartered in Miami, Florida. Carnival Corporation operates as a subsidiary of Carnival Corporation & Plc.

Monster Beverage Corporation (MNST) dropped $-0.48 to close the day at a new closing price of $43.46, a -1.09% decrease in value from its previous closing price that moved the stock 15.3% above its 52 week low of $37.69. A total of 3.18M shares exchanged hands during the day compared with its three month average trading volume of 3.27M. The stock, which fluctuated between $43.14 and $44.15 during the day, currently situated -21.69% below its 52 week high. The stock is down by -1.87% in the past one month and down by -9.65% over the past three months. With a one year target estimate of $54.07 and RSI of 45.88, the stock still has upside potential, making it a hold for now.

Monster Beverage Corporation, through its subsidiaries, develops, markets, sells, and distributes energy drink beverages and its concentrates in the United States and internationally. It operates through three segments: Finished Products, Concentrate, and Other. The company provides carbonated energy, and non-carbonated dairy based coffee and energy drinks to full service beverage distributors, retail grocery and specialty chains, wholesalers, club stores, drug chains, mass merchandisers, convenience chains, health food distributors, food service customers, and the military; and concentrates and/or beverage bases to authorized bottling and canning operations. Monster Beverage Corporation sells its products under the Monster Energy, Nalu, Monster Rehab, NOS, Monster Energy Extra Strength Nitrous Technology, Full Throttle, Java Monster, Burn, Muscle Monster, Mother, Mega Monster Energy, Ultra, Punch Monster, Play and Power Play, Juice Monster, Gladiator, M3, Relentless, Übermonster, Samurai, BU, and BPM brands. The company was formerly known as Hansen Natural Corporation and changed its name to Monster Beverage Corporation in January 2012. Monster Beverage Corporation was founded in 1985 and is headquartered in Corona, California.